Sydney Health Ethics: Recent submissions
-
Global bionetworks and challenges in regulating autologous adult stem cells
Published 2013-01-01Autologous adult stem cells (ASCs) are increasingly being administered to patients with limited evidence from clinical trials that they are safe and effective. The marketing of autologous ASCs predominantly over the Internet ...Open AccessArticle -
Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First-in-Human Trials of Induced Pluripotent Stem (iPS) Cells
Published 2013-01-01The discovery of induced pluripotent stem (iPS) cells in 2006 was heralded as a major breakthrough in stem cell research. Since then, progress in iPS cell technology has paved the way towards clinical application, particularly ...Open AccessArticle -
Tempering hope with realism. Induced pluripotent stem cells in regenerative medicine
Published 2012-01-01• Since their discovery in 2007, human induced pluripotent stem (iPS) cells have been widely championed as the future for regenerative medicine. • By differentiating iPS cells into specialised cells for transplantation, ...Open AccessArticle -
Rhetoric, power and legitimacy: A critical analysis of the public policy disputes surrounding stem cell research in Australia (2005-6).
Published 2012-01-01In December 2006, the Australian Parliament liberalized regulation governing stem cell research. This decision and preceding legislative review generated considerable public debate, which centred on objections to the ...Open AccessArticle -
Community treatment orders in Australia: rates and patterns of use.
Published 2012-01-01Objectives: Community treatment orders (CTOs) allow clinicians to provide unconsented outpatient treatment to people living with mental illness. Though controversial and of uncertain efficacy, CTOs are used throughout ...Open AccessArticle